|255 Liberty Street , New York, NY 10286|
|Fund Manager||Team Managed|
The Fund seeks long-term capital growth consistent with the preservation of capital; current income is a secondary goal.To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the common stock of U.S. and foreign companies. The fund focuses on "blue chip" multinational companies with total market values of more than $5 billion. These are large, established, globally managed companies that manufacture and distribute their products and services throughout the world.In choosing stocks, the fund's portfolio managers first identify economic sectors that they believe will expand over the next three to five years or longer. Using fundamental analysis, the fund's portfolio managers then seek companies within these sectors that have demonstrated sustained patterns of profitability, strong balance sheets, an expanding global presence and the potential to achieve predictable, above-average earnings growth. Under normal circumstances, at least 40% of the fund's assets will be invested in companies that have significant exposure to the economies of countries other than the United States. These are companies that are organized or domiciled in a foreign country or have at least 50% of their assets outside the U.S. or at least 50% of their revenues or profits are from goods produced or sold, investments made, or services performed outside the United States. These companies may be subject to the risks that are involved in investing in foreign securities. The fund also invests in U.S. dollar-denominated American Depositary Receipts (ADRs).The fund employs a "buy-and-hold" investment strategy, which is an investment strategy characterized by a low portfolio turnover rate, which helps reduce the fund's trading costs and minimizes tax liability by limiting the distribution of capital gains.
|Asset Type||% Of Allocation|
|Total Net Assets||730.03 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$750|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
Join the Action Alerts PLUS Community today!
Novavax and Serum Institute of India have applied to the WHO for an emergency use listing of Novavax's Covid-19 vaccine.
Rite Aid stock has one key support level left before more potential downside. Investors trading the stock should keep that level in mind.
Measure to allow banks to finance the cannabis industry passes voice vote in U.S. House.
Stocks surge amid the Fed's patience on tapering and amid cautious optimism for a brokered solution to the Evergrande debt crisis.
Joby is 'a first mover to address the urban air mobility market,' which Morgan Stanley sees at $1 trillion in 2040 and $9 trillion in 2050.
Guggenheim raised Roku to a buy based on the streaming-tech company's growth potential overseas and more potent advertising capabilities.